Neurizon Therapeutics Limited (ASX:NUZ)
Australia · Delayed Price · Currency is AUD 0.1700
+0.0100 (6.25%)
At close: Jul 31, 2025, 4:00 PM AEST
Neurizon Therapeutics Market Cap
Neurizon Therapeutics has a market cap or net worth of 83.69 million as of August 1, 2025. Its market cap has decreased by -10.45% in one year.
Market Cap
83.69M
Enterprise Value
73.58M
Revenue
1.52M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.17
Market Cap Chart
Since September 12, 2002, Neurizon Therapeutics's market cap has increased from 4.18M to 83.69M, an increase of 1,900.67%. That is a compound annual growth rate of 13.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 1, 2025 | 83.69M | - |
| Dec 31, 2024 | 83.69M | 94.55% |
| Dec 29, 2023 | 43.02M | 112.09% |
| Dec 30, 2022 | 20.28M | -36.00% |
| Dec 31, 2021 | 31.69M | -4.63% |
| Dec 31, 2020 | 33.23M | 2.35% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 127.86B |
| Pro Medicus | 32.80B |
| Cochlear | 20.43B |
| Sonic Healthcare | 13.51B |
| Ramsay Health Care | 8.74B |
| Telix Pharmaceuticals | 6.82B |
| Ansell | 4.35B |
| Mesoblast | 3.01B |